SA
Sign upLog In
LHX

LHX R&D Expenses

$438.00MTTM · USD

Period ending:

QuarterlyTTMAnnualChart Studio →
LHX FY R&D ExpensesUSD
LHX FY R&D Expenses1986-06-30: $0.001987-06-30: $0.001988-06-30: $0.001989-06-30: $0.001990-06-30: $0.001991-06-30: $0.001992-06-30: $0.001993-06-30: $0.001994-06-30: $0.001995-06-30: $0.001996-06-30: $0.001997-06-30: $0.001998-06-30: $0.001999-06-30: $0.002000-06-30: $0.002001-06-30: $0.002002-06-30: $0.002003-06-30: $0.002004-06-30: $0.002005-06-30: $0.002006-06-30: $0.002007-06-30: $0.002008-06-30: $0.002009-06-30: $0.002010-06-30: $0.002011-06-30: $0.002012-06-30: $0.002013-06-28: $0.002014-06-27: $0.002015-07-03: $0.002016-07-01: $0.002017-06-30: $0.002018-06-29: $0.002019-06-28: $0.002019-12-31: $0.002021-01-01: $0.002021-12-31: $0.002022-12-30: $603.00M2023-12-29: $480.00M2025-01-03: $515.00M2026-01-02: $536.00M$603.00M$0.00
1986-06-302026-01-02

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LHX r&d expenses history

Research and development spending. The available annual fiscal periods series contains 41 observations from Jun 30, 1986 to Jan 2, 2026.

L3Harris R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
536,000,000
515,000,000
480,000,000
603,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Compare r&d expenses

All LHX financial metrics · LHX stock overview · How to interpret financial metrics

Explore More

Industrial Stocks

More Industrials stocks

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.